Literature DB >> 20890146

The oncologist's role in managing depression, anxiety, and demoralization with advanced cancer.

Simon Wein1, Aaron Sulkes, Salomon Stemmer.   

Abstract

The incidence of psychological distress-depression, anxiety, delirium-in patients with cancer ranges from 35% to 50%. Demoralization, a new concept, has not been included in most studies. The role of the oncologist in managing depression, anxiety, and demoralization involves diagnosing the problem, providing verbal support, first-line psychotropic medications, and referral to the psycho-oncology team. Empirical studies have shown that oncologists have difficulties in recognizing psychological stress and talking with patients about it. Reasons include a belief that distress is "normal"; the subject matter is embarrassing and uncomfortable; they feel unskilled; and time constraints. Therefore, the role of communication training in medical school and for oncologists in training is important. Screening for psychological distress may identify patients; however, inadequate psychosocial follow up and support may make screening counterproductive. Depression and anxiety constitute most psychological distress and will be described in formal psychiatric terms (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) and subjective descriptions. Demoralization, a concept recently introduced to psycho-oncology, is reviewed. Demoralization acts as a bridge from traditional psychiatric terminology to newer concepts used to describe the particular psychological distress characteristic of advanced cancer. Word concepts, such as meaning, spiritual, dignity, and existential, capture the patients' distress that is not defined by formal psychiatric taxonomy. Management modalities for depression, anxiety, and demoralization are discussed.

Entities:  

Mesh:

Year:  2010        PMID: 20890146     DOI: 10.1097/PPO.0b013e3181f28b64

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  7 in total

1.  The benefits of psychosocial interventions for cancer patients undergoing radiotherapy.

Authors:  Zhen Guo; Hua-Ying Tang; Hao Li; Sheng-Kui Tan; Kai-Hua Feng; Yin-Chun Huang; Qing Bu; Wei Jiang
Journal:  Health Qual Life Outcomes       Date:  2013-07-17       Impact factor: 3.186

2.  Incidence and drug treatment of emotional distress after cancer diagnosis: a matched primary care case-control study.

Authors:  F Desplenter; C Bond; M Watson; C Burton; P Murchie; A J Lee; K Lefevre; S Simoens; G Laekeman
Journal:  Br J Cancer       Date:  2012-10-11       Impact factor: 7.640

3.  POSITIVE study: physical exercise program in non-operable lung cancer patients undergoing palliative treatment.

Authors:  Joachim Wiskemann; Simone Hummler; Christina Diepold; Melanie Keil; Ulrich Abel; Karen Steindorf; Philipp Beckhove; Cornelia M Ulrich; Martin Steins; Michael Thomas
Journal:  BMC Cancer       Date:  2016-07-19       Impact factor: 4.430

Review 4.  Depressive Spectrum Disorders in Cancer: Diagnostic Issues and Intervention. A Critical Review.

Authors:  Rosangela Caruso; Maria GiuliaNanni; Michelle B Riba; Silvana Sabato; Luigi Grassi
Journal:  Curr Psychiatry Rep       Date:  2017-06       Impact factor: 5.285

5.  Physicians' attitudes towards psycho-oncology, perceived barriers, and psychosocial competencies: Indicators of successful implementation of adjunctive psycho-oncological care?

Authors:  Bianca Senf; Jens Fettel; Christina Demmerle; Paula Maiwurm
Journal:  Psychooncology       Date:  2018-12-21       Impact factor: 3.894

6.  Serotonin transporter gene (SLC6A4) variations are associated with poor survival in colorectal cancer patients.

Authors:  Sevtap Savas; Angela Hyde; Susan N Stuckless; Patrick Parfrey; H Banfield Younghusband; Roger Green
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

7.  Psychotropic medication utilisation in adult cancer patients in China: A cross-sectional study based on national health insurance database.

Authors:  Lin Bai; Ziyue Xu; Cong Huang; Yunchuan Sui; Xiaodong Guan; Luwen Shi
Journal:  Lancet Reg Health West Pac       Date:  2020-11-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.